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Changes in Childhood Body-Mass Index and Risk of Venous
Thromboembolism in Adulthood
Jens Sundbøll, MD, PhD; Lars €Angquist, PhD; Kasper Adelborg, MD, PhD; Line Klingen Gjærde, MD, PhD; Anne Ording, PhD;
Thorkild I. A. Sørensen, MD, DMSci; Jennifer L. Baker, PhD; Henrik Toft Sørensen, MD, PhD, DMSci
Background-—Childhood weight trajectories may inﬂuence cardiometabolic traits and thereby the risk of venous thromboembolism
(VTE) later in life. We examined whether overweight and changes in weight status during childhood were associated with risk of VTE
in adulthood.
Methods and Results-—We used Danish medical registries to conduct a population-based cohort study of Danish schoolchildren
aged 7 to 13 years and born during 1930-1989. We calculated body-mass index (BMI) z-scores based on weight and height
measurements. We estimated hazard ratios using Cox regressions to examine associations between changes in BMI z-scores from
7 to 13 years of age and the subsequent risk of VTE. Among 313 998 children, 5007 girls and 5397 boys were diagnosed with VTE
as adults. Compared with children with a normal BMI (25th to 75th percentile category) at both ages, children with a BMI
persistently above the 75th percentile had a 1.30- to 1.50-fold increased risk of VTE in adulthood. Children who experienced a BMI
increase from the 25th to 75th or >75th to 90th percentile to a higher percentile category had a 1.35- to 1.70-fold increased risk
of adulthood VTE. Children whose BMI percentile category decreased between 7 and 13 years of age had a VTE risk similar to that
of children with a persistently normal BMI.
Conclusions-—Risk of VTE in adulthood was higher in children with a persistently above-average BMI. Whereas weight gain from 7
to 13 years of age additionally increased VTE risk, remission from overweight by 13 years of age completely reverted the risk.
( J Am Heart Assoc. 2019;8:e011407. DOI: 10.1161/JAHA.118.011407.)
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T he global obesity epidemic affects 38% of the adultpopulation and is spreading progressively to younger age
groups.1 In high-income countries, 20% of children aged 5 to
19 years are now classiﬁed as overweight.2 This prevalence
among contemporary children reﬂects an almost 50%
increase during the past 35 years1—a pattern that is
expected to continue.3
Strong evidence suggests that factors acting throughout
life contribute to the risk of cardiovascular disease. Evidence
from observational studies indicates an inverse association
between birth weight and the risk of myocardial infarction and
stroke later in life.4,5 This has been explained by fetal
programming and in utero modiﬁcation of genetic
expression.6 During postnatal growth, childhood overweight
and obesity are associated with both coronary artery disease7
and ischemic stroke in adulthood.8
It remains unclear if early growth patterns are also
related to venous thromboembolism (VTE) in adulthood.
Evidence of a relationship between atherosclerotic diseases
and VTE is increasing.9-13 However, whether the association
is causal or explained by shared risk factors is unknown.
Recent publications have shown that conventional cardio-
vascular disease risk factors are not associated with
increased VTE risk,14 and adjusting for such risk factors
does not change the association between obesity and VTE in
adults.15
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To develop early preventive strategies, it is important to
establish whether childhood overweight is a risk factor for VTE
in adulthood and to understand whether this risk is reversible
if normal weight is achieved before adolescence. Therefore,
we investigated whether overweight and changes in weight
status during childhood were associated with a later risk of
VTE in a large cohort of children followed through adulthood.
Methods
Setting and Design
This population-based cohort study included children born
between 1930 and 1989 who took part in mandatory annual
health examinations at public and private schools in Copen-
hagen, Denmark. The Danish Civil Registration System, which
was established in 1968, records the civil and vital status for
each Danish resident through a unique personal identiﬁcation
number assigned at birth or on immigration. The personal
identiﬁcation number allows for individual-level linkage among
an array of Danish registries.16
Body-Mass Index
The annual examinations included measurements of the
children’s weight and height when they were naked or
wearing light clothing. The successive weight and height
measures were noted on a personal health card including the
child’s name, date of birth, and birth weight as reported by the
parents (since birth year 1936). These data have been stored
digitally in the Copenhagen School Health Records Register.17
We successfully linked 88% of the records to the Civil
Registration System. The main reason for linkage failure was
death or emigration before 1968.17
We calculated each child’s body-mass index (BMI) from 7
through 13 years of age as the body weight in kilograms
divided by the squared height in meters. Using data from
1955 to 1960, we created internal age- and sex-speciﬁc BMI
references. BMI z-scores were calculated using the lambda-
mu-sigma method.18 Z-scores were estimated by interpolation
or extrapolation in a 12-month time window unless
measurements were recorded on the child’s birthday.
Venous Thromboembolism
We used the Danish National Patient Register, covering all
Danish hospitals,19 to identify ﬁrst-time VTE events, collaps-
ing deep venous thrombosis and pulmonary embolism, as
these have been regarded as clinical manifestations of the
same disease process. We included ﬁrst-time VTE events
based on inpatient or outpatient admissions coded according
to the International Classiﬁcation of Diseases, Eighth Revision
(ICD-8) until the end of 1993 and Tenth Revision (ICD-10)
thereafter (Table S1). The Danish National Patient Register
contains data on admission and discharge dates from all
Danish nonpsychiatric hospitals since 1977 and from outpa-
tient clinics since 1995.19
Statistical Analysis
We followed all children who could be successfully linked to
the Civil Registration System from the date of their 25th
birthday (as VTE at younger ages is uncommon and likely
related to congenital thrombogenic disorders) or from January
1, 1977 (when the Danish National Patient Register was
established), whichever occurred later. The index date was
deﬁned as the date of commencement of follow-up, which
continued for each individual until a hospital admission or
outpatient visit for VTE, death, emigration, or December 31,
2014, whichever occurred ﬁrst.
Because the risk factors for the development of VTE differ
for men and women,20,21 we performed all analyses sepa-
rately by sex. We calculated incidence rates for VTE and used
Cox proportional-hazard regression analyses with age as the
underlying time scale to examine associations between BMI z-
scores and risk of VTE.
We performed categorical analyses based on the <10th,
10th to <25th, 25th to 75th (reference), >75th to 90th, and
>90th percentiles of age- and sex-speciﬁc BMI distributions.
In addition to categorical analyses, we analyzed BMI z-scores
as a continuous variable. Potential nonlinearity in the
Clinical Perspective
What Is New?
• Children with obesity have a cardiometabolic risk proﬁle
that may predispose them to venous thromboembolism
later in life.
• We show that the risk of venous thromboembolism in
adulthood was higher in children with a persistently above-
average body-mass index.
• Whereas weight gain from 7 to 13 years of age additionally
increased risk of venous thromboembolism, remission from
overweight by 13 years of age completely reverted the risk.
What Are the Clinical Implications?
• Our observations suggest that childhood overweight may be
an important modiﬁable risk factor for venous thromboem-
bolism in adulthood.
• Because more children are becoming heavier at progres-
sively younger ages, our results merit focus on helping
children to attain and maintain appropriate weight to
prevent cardiovascular disease in adulthood.
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associations between BMI z-scores and VTE was tested
against a restricted cubic spline with 4 knots.22 We found
indications of nonlinearity for both sexes (majority of P<0.05).
Therefore, we present these results using spline models.
Because the patterns of associations were comparable at all
ages, we only present the results for 7 and 13 years of age.
Results for intermediate ages are shown in Table S2. To
distinguish cases of VTE with and without known predisposing
conditions, we analyzed the risks of provoked and unprovoked
VTE separately, deﬁning “provoked” VTE as the presence of a
preceding malignancy (any time before the VTE diagnosis) or
pregnancy/delivery, trauma/fracture, or surgery (within
90 days before the VTE diagnosis).23
In the cohort of individuals for whom birth-weight data
were available, we examined their association with VTE using
categorical and spline models. In addition, we investigated in
spline models the possible inﬂuence of birth weight by testing
interactions between dichotomized birth weight and BMI on
the risk of VTE using a likelihood ratio test and by adjusting
for birth weight. All analyses were stratiﬁed by birth cohort
(1930-1939, 1940-1949, 1950-1959, 1960-1969, 1970-
1979, and 1980-1989), allowing the baseline hazard to differ
for each birth cohort. In addition, we tested for potential
interactions with birth cohorts in both categorical and spline
models.
Proportional hazard assumptions were assessed by split-
ting the age-at-risk observation time into groups (based on
age quartiles at VTE diagnosis) and performing corresponding
interaction tests. P<0.05 held only for boys at 7 and 8 years
of age. Thus, the proportional hazards assumption was not
violated (Table S3).
To evaluate the impact of changes in BMI during childhood,
we computed hazard ratios for VTE comparing children who
changed BMI percentile categories between 7 and 13 years of
age with children who maintained BMIs in the reference
category (25th-75th percentile) at both ages. This analysis
was based on percentiles of age- and sex-speciﬁc BMI
distributions provided by the Centers for Disease Control and
Prevention,24 where “overweight” is equivalent to the 90th
percentile of BMI in our data.
Because deep venous thrombosis and pulmonary embo-
lism were collapsed into a single entity (venous thromboem-
bolism) in the main analysis, we performed a sensitivity
analysis of categorical data separately for deep venous
thrombosis and pulmonary embolism to test the robustness of
this approach. In a sensitivity analysis we also calculated
E-values for selected representative estimates and the
corresponding lower limit of the 95% CI for boys and girls
aged 13 years with BMI z-scores of 0.68 to 1.28. This allowed
us to assess how strong an unmeasured confounder would
have to be to explain away the observed exposure-outcome
association.25
All statistical analyses were performed using Stata statis-
tical software version 14.2 (StataCorp LP, College Station, TX;
www.stata.com). The study was approved by the Danish Data
Protection Agency (record number 2012-58-0004). According
to Danish legislation, no approval from an ethics committee or
informed consent from patients is required for register-based
studies in Denmark.26 The data that support the ﬁndings of
this study are available from the corresponding author on
reasonable request.
Results
We identiﬁed a total study population of 372 636 children.
After excluding individuals who did not have a personal
identiﬁcation number, individuals who had emigrated, died, or
had VTE before age 25 years, or individuals with no BMI
information, 313 998 children (154 987 girls and 159 011
boys) remained in the study (Figure 1). During 8 582 910
person-years of follow-up, 5007 girls and 5397 boys were
diagnosed with ﬁrst-time VTE later in life. As expected, the
incidence rate of VTE increased with advancing age and was
moderately higher in men than in women (Figure S1).
Childhood Body-Mass Index and Risk of Venous
Thromboembolism
Across sex and age, children with a BMI in the >75th to 90th
percentile had a moderately increased risk of VTE in
adulthood compared with children with a BMI in the 25th
to 75th percentile, whereas a BMI above the 90th percentile
was associated with a substantially increased risk (Table 1).
For women with a childhood BMI above the 90th percentile at
7 or 13 years of age, the risk of VTE was 1.46-fold and 1.61-
fold higher, respectively. For men with a childhood BMI above
the 90th percentile at 7 or 13 years of age, the risk of VTE
was 1.28-fold and 1.50-fold higher, respectively. The asso-
ciations were comparable in analyses stratiﬁed by provoked
and unprovoked VTE (Table S4). About one third of VTE cases
were provoked; of these, 1852 were cancer related (1000
women and 852 men), 96 were pregnancy related (only
women), 628 were fracture related (282 women and 346
men), and 1969 were surgery related (1018 women and 951
men). Of note, a single individual could have more than 1
provoking factor registered, and VTE events stratiﬁed by
provoking factors exceeded the total number of unique VTE
events. The results remained largely unchanged when we
separately analyzed deep venous thrombosis and pulmonary
embolism (Table S5).
For boys aged 13 years (hazard ratio [HR] 1.13, 95% CI
1.04-1.22), the E-value was 1.51 for BMI z-scores of 0.68 to
1.28 (E-value for lower limit of 95% CI=1.24). For girls aged
DOI: 10.1161/JAHA.118.011407 Journal of the American Heart Association 3
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13 years (HR 1.14, 95% CI 1.05-1.24), the E-value was 1.54
for BMI z-scores of 0.68 to 1.28 (E-value for lower limit of 95%
CI was 1.28).
The results from the categorical analyses were reﬂected in
the spline regression analyses (Figure 2) in which above-
average BMI z-scores among boys at 7 or 13 years of age
were positively associated with VTE in adulthood, with the
strongest associations between BMI z-scores at 13 years and
subsequent VTE. The same pattern was observed in girls with
above-average BMI z-scores. Below-average childhood BMI
values were associated with a marginally decreased risk of
VTE, especially for boys with below-average BMI at 13 years
of age. We observed no birth cohort effects in the categorical
or spline models (data not shown).
Eligible population alive and living in Denmark at age 25 years
n = 319,927 (157,743 women/162,184 men)
Emigration, death, or loss to follow-up 
prior to 25 years of age
or January 1, 1977
n = 9,821 (4,708 women/5,113 men)
Starting population
n = 329,748 (162,451 women/167,297 men)
Sample included in the analysis 
n = 313,998 (154,987 women/159,011 men)
Venous thromboembolism diagnosis at 
< 25 years of age
n = 197 (132 women/65 men)
Missing measurement of body mass 
index and/or height at any age
n = 5,723 (2,620 women/3,103 men)
Outlier measure for body mass index
 and/or height at any age
n = 9 (4 women / 5 men)
Total population in the Copenhagen School 
Health Records Register born during 1930-1989
n = 372,636 (184,276 women/188,360 men)
Lack of personal identification number
n = 42,888 (21,825 women/21,063 
men)
Figure 1. Inclusion of children in the study.
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In the 117 418 girls and 122 538 boys who had data
available on birth weight, 3736 girls and 3241 boys were
diagnosed with VTE in adulthood. For these individuals, we
found no association between low birth weight and VTE in
adulthood (data not shown). Adjusting for birth weight did
not change the associations between BMI z-score and the
risk of VTE in adulthood (Figure S2). In girls with birth weight
z-scores ≤0, we observed a moderately strengthened
association between BMI at 7 and 13 years of age and risk
of VTE in adulthood (Figure S3). In boys we observed no
interactions between birth weight and BMI on VTE risk at
any age.
BMI Percentile Change During Childhood and Risk
of VTE
The analyses of changes in BMI included 253 578 children
(126 277 girls and 127 301 boys). Children with normal weight
at 7 and 13 years of age (BMI within the 25th-75th percentile
deﬁned by the Centers for Disease Control and Prevention)
constituted the reference group in all comparisons. Children
with a persistently above-average BMI had a 1.28- to 2.43-fold
higher risk of VTE in adulthood (Table 2). Children who gained
weight from the 25th to 75th percentile at 7 years of age to
either the >75th to 90th or >90th percentile at 13 years of age
had a 1.29- to 2.87-fold higher risk of VTE during adulthood.
Girls in either the >75th to 90th or >90th percentile at 7 years
of age who thenmoved down 1 BMI category by 13 years of age
had the same risk of VTE in adulthood as girls in the reference
group. Boyswhomoved down from the>75th to 90th percentile
at 7 years of age to the 25th to 75th percentile at 13 years of
age also had the same risk as the reference group. In contrast,
boys who moved down from the >90th percentile to the >75th
to 90th percentile remained at a 2-fold higher risk of VTE in
adulthood.
Discussion
In this population-based cohort study of 313 998 schoolchil-
dren, above-average BMI at 7 or 13 years of age was
associated with an increased risk of VTE in adulthood.
Children with persistently above-average BMI at 7 and
13 years of age had an additionally increased risk of VTE in
adulthood, whereas overweight children who normalized
their BMI by 13 years of age had VTE risks comparable to
those who were consistently normal weight. These results
were consistent across sex and birth cohorts. The associ-
ation between childhood BMI and risk of VTE in adulthood
was moderately strengthened among girls with a birth-
weight z-score ≤0. However, we found no association
between low birth weight and VTE in adulthood. Moreover,
adjusting for birth weight did not change the results
appreciably.
Two previous case-control studies27,28 examined the risk
of childhood-onset VTE in obese children. Both studies
involved a single institution, <100 VTE cases, and controls
selected from patients admitted with other diseases. These
studies reported a 2- to 3-fold increased risk of VTE in obese
children compared with normal-weight children (odds
ratio=2.1; 95% CI 1.1-4.227 and odds ratio=3.1; 95% CI 4.1-
7.028)—similar to the risks described in adult cohorts.29-31
However, although obesity is an important and well-estab-
lished risk factor for VTE in both children and adults,32
previous studies of children27,28 have not provided follow-up
into adulthood. A Danish cohort study of 6502 young adult
men (median age 19 years) undergoing ﬁtness examinations
Table 1. BMI Category and Risk of Venous Thromboembolism in Adulthood, by Age and Sex
Age, y BMI z-Score Category BMI Percentile
Female Male
BMI Equivalent (kg/m2) No. of Events HR (95% CI)
BMI Equivalent
(kg/m2) No. of Events HR (95% CI)
7 4.5 to 1.28 <10th <13.8 440 0.97 (0.88-1.07) <14.0 419 0.84 (0.76-0.93)
1.28 to 0.68 10th to <25th 13.8 to <14.5 671 0.94 (0.86-1.02) 14.0-<14.6 789 1.00 (0.92-1.08)
0.68 to 0.68 25th to 75th 14.5 to 16.3 22 328 1.00 (reference) 14.6 to 16.3 2592 1.00 (reference)
0.68 to 1.28 >75th to 90th >16.3 to 17.3 714 1.12 (1.03-1.22) >16.3 to 17.2 788 1.10 (1.01-1.19)
1.28 to 4.50 >90th >17.3 513 1.46 (1.32-1.60) >17.2 487 1.28 (1.16-1.41)
13 4.5 to 1.28 <10th <15.7 379 0.90 (0.81-1.00) <15.6 399 0.84 (0.76-0.93)
1.28 to 0.68 10th to <25th 15.7 to <16.7 618 0.90 (0.82-0.98) 15.6-<16.5 689 0.90 (0.83-0.98)
0.68 to 0.68 25th to 75th 16.7 to 19.9 2323 1.00 (reference) 16.5 to 19.4 2555 1.00 (reference)
0.68 to 1.28 >75th to 90th >19.9 to 21.9 750 1.14 (1.05-1.24) >19.4 to 21.1 794 1.13 (1.04-1.22)
1.28 to 4.50 >90th >21.9 578 1.61 (1.47-1.76) >21.1 559 1.50 (1.37-1.65)
BMI indicates body-mass index (kg/m2); HR, hazard ratio.
DOI: 10.1161/JAHA.118.011407 Journal of the American Heart Association 5
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for army conscription examined overweight in relation to the
risk of VTE. The study found that men with obesity
(BMI≥30 kg/m2) had an almost 5-fold increased risk of VTE
later in life (HR 4.7; 95% CI 1.9-11.9), whereas men who were
overweight (BMI 25 to <30 kg/m2) had no increased risk
compared with young men with BMI values between 18.5 and
25 kg/m2.33 In contrast, we found that BMI values even
below the current childhood BMI classiﬁcation of “overweight”
used by the Centers for Disease Control and Prevention in the
United States (equivalent to the 90th percentile of BMI in our
study24) were associated with an increased risk of VTE in
adulthood, pointing to an important association with even
marginally increased BMI in childhood. This ﬁnding is notable
and may indicate the need for increased clinical attention,
especially considering the abundance of children in this
category.
In our analyses of change in BMI percentile during childhood,
we observed that children whowere initially overweight but who
had achieved normal weight before 13 years of age were not at
increased risk of VTE in adulthood. This indicates that
overweight in childhood may be a modiﬁable risk factor with
the potential to prevent VTE. Contrary to these ﬁndings, weight
loss has been associated with increased risk of provoked VTE in
adults.32 This difference may exist because weight loss in
adulthood can be an indicator of underlying disease, particularly
cancer, whereas this factor only exceptionally may be the cause
of weight loss in childhood.
Several putative mechanisms may be at the root of the
observed associations. Shared determinants of later-onset
overweight and VTE may already exist in utero and involve the
individual’s speciﬁc gene pool and exposure to maternal
lifestyle.6 Also, being overweight in childhood may correlate
with overweight in adulthood and reﬂect a life-long sedentary
lifestyle that facilitates low-ﬂow conditions and thrombus
formation in the venous system. Childhood overweight often
continues into young adulthood.34 The derived risk for VTE is
likely maintained, although the association between childhood
BMI and middle to late adulthood BMI is weak.34 We could not
examine the cardiometabolic trajectories because adult
weight and cardiovascular risk factors have complex patterns
over a lifetime, and adult weight preceding the occurrence of
VTE could not be retrieved for this study.
An important strength of our study is the use of
prospectively collected data on essentially every school child
in the Copenhagen municipality from 1930 to 1989. Health
examinations were mandatory at all public and private
schools, which reduced selection bias stemming from differ-
ences in socioeconomic status or other possibly relevant
factors. We were able to follow study participants over several
decades of adulthood and had virtually no loss to follow-up
(<0.1%). The diagnosis of VTE in the Danish National Patient
Register is valid for use in research, with a positive predictive
value of 90%.35 Due to its acute onset, accompanying
discomfort, and severe course, we assume that VTE rarely
Figure 2. Restricted cubic spline models for the association between body-mass index (BMI) at 7 and
13 years of age and venous thromboembolism in adulthood.
DOI: 10.1161/JAHA.118.011407 Journal of the American Heart Association 6
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remains undetected. Thus, the outcome accuracy was favor-
able, and the likelihood of misclassiﬁcation was low.
Several limitations must be considered in assessing our
ﬁndings. We lacked information on socioeconomic status and
smoking habits of the children and their parents. However,
despite temporal changes in socioeconomic differences
within birth cohorts and smoking habits, our results were
consistent across all birth cohorts, indicating a minor role of
such potential confounders. In support of this supposition, the
derived E-values indicating the strength of association with
both the exposure and the outcome needed by an unmea-
sured confounder to potentially (as a maximum) explain away
Table 2. Hazard Ratios for the Association Between Different Patterns of Change in BMI Between 7 and 13 Years of Age and
Diagnosis of VTE in Adulthood
BMI Percentile at Age 7 y*
BMI Percentile at Age 13 y*
<5th 5th to <25th 25th to 75th >75th to 95th >95th
Women
<5th
No. of cases/total no.† 78/2378 86/2440 28/778 2/20 0/0
Hazard ratio (95% CI) 0.99 (0.79-1.24) 1.01 (0.81-1.25) 1.05 (0.72-1.52)  
5th to <25th
No. of cases/total no.† 76/2777 389/12 517 383/10 324 11/334 0/5
Hazard ratio (95% CI) 0.82 (0.66-1.04) 0.85 (0.77-0.95) 1.01 (0.90-1.12) 1.04 (0.58-1.88) 
25th to 75th
No. of cases/total no.† 10/545 364/11 843 1911/52 511 333/7829 7/100
Hazard ratio (95% CI) 0.61 (0.33-1.13) 0.88 (0.78-0.98) 1.00 (reference) 1.29 (1.14-1.44) 2.87 (1.37-6.03)
>75th to 95th
No. of cases/total no.† 0/0 3/114 211/7033 353/8357 29/660
Hazard ratio (95% CI)   0.91 (0.79-1.05) 1.35 (1.20-1.51) 1.91 (1.32-2.76)
>95th
No. of cases/total no.† 0/0 0/0 2/77 29/787 27/516
Hazard ratio (95% CI)    1.36 (0.94-1.96) 2.42 (1.65-3.54)
Men
<5th
No. of cases/total no.† 73/3035 75/2218 29/544 1/26 0/0
Hazard ratio (95% CI) 0.68 (0.54-0.86) 0.89 (0.71-1.13) 1.54 (1.07-2.23)  
5th to <25th
No. of cases/total no.† 114/3393 473/13 423 300/7048 16/268 1/2
Hazard ratio (95% CI) 0.91 (0.76-1.10) 0.89 (0.81-0.98) 1.11 (0.98-1.25) 1.95 (1.20-3.20) 
25th to 75th
No. of cases/total no.† 21/750 553/15 954 2025/51 362 271/5915 6/165
Hazard ratio (95% CI) 0.86 (0.56-1.32) 0.88 (0.80-0.97) 1.00 (reference) 1.35 (1.19-1.54) 1.48 (0.66-3.30)
>75th to 95th
No. of cases/total no.† 0/2 6/168 353/8837 307/7459 26/666
Hazard ratio (95% CI)  1.02 (0.46-2.27) 1.08 (0.97-1.21) 1.28 (1.14-1.45) 1.68 (1.14-2.47)
>95th
No. of cases/total no.† 0/0 0/0 4/73 35/662 28/614
Hazard ratio (95% CI)    2.01 (1.44-2.80) 2.43 (1.67-3.53)
Hazard ratios were not calculated for these BMI categories due to <5 available events. BMI indicates body-mass index (kg/m2); VTE, venous thromboembolism.
*Based on age- and sex-speciﬁc BMI distributions provided by the Centers for Disease Control and Prevention.
†Data in this row are the number of cases of venous thromboembolism diagnosed in adulthood and the total number of children with the given BMI pattern.
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selected representative ﬁndings (HR 1.13-1.14) were rela-
tively large (E-values: 1.51-1.54) in comparison. This indicates
that our ﬁndings are likely robust to effects of potential
unmeasured and uncontrolled confounding. Finally, although
our data are longitudinal, we were unable to clarify whether
the associations were generated through metabolic effects of
overweight in childhood or in adulthood—in the latter case
because of retaining overweight status from childhood
through adulthood.
In this study we demonstrated that, compared with normal-
weight children, above-average BMI in childhood was associ-
ated with greater risk of VTE in adulthood. Furthermore,
weight gain during childhood additionally increased this risk.
Among overweight children who were able to normalize their
weight before adolescence, the risk of VTE was the same as
for children with normal weight throughout childhood. These
observations suggest that childhood overweight may be an
important modiﬁable risk factor for VTE in adulthood.
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Table S1. Definition of venous thromboembolism and provoked venous thromboembolism, 
according to codes in the International Classifications of Diseases, Eighth and Tenth 
Revisions (ICD-8 and ICD-10). 
ICD-8 ICD-10 Other codes 
Definition of venous thromboembolism. 




Pulmonary embolism 450.99 I26.0, I26.9 
Definition of provoked venous thromboembolism. We defined patients with ‘provoked’ venous thromboembolism as 
those with a hospital discharge diagnosis of malignancy (any time before the venous thromboembolism diagnosis) or 
pregnancy/delivery, trauma/fracture, or surgery (within 90 days preceding the date of the venous thromboembolism 
diagnosis). 
Cancer (including polycythemia vera 
and essential thrombocythemia), any 
previous diagnosis 
140–209, 28710 C00–C99, D45, 
D473 





Surgery within previous 90 days Previous Danish Classification up 
to 1996: 000000-99960; Nordic 
Medico-statistical Committee’s 
Classification of Surgical 
Procedures after 1996: KA-KQ, 
KX, KY 
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Table S2. Body-mass index category and risk of venous thromboembolism in adulthood for children at ages 8, 9, 10, 11, and 12 years, 
















HR (95% CI) 
8 -4.5 to -1.28 <10th <14.0 346 0.97 (0.87–1.08) <14.2 298 0.77 (0.68–0.87) 
-1.28 to -0.68 10th–<25th 14.0–<14.7 663 0.91 (0.84–1.00) 14.2–<14.9 739 1.01 (0.93–1.09) 
-0.68 to 0.68 25th–75th 14.7–16.7 2615 1.00 (reference) 14.9–16.7 2939 1.00 (reference) 
0.68 to 1.28 >75th–90th >16.7–17.9 672 1.15 (1.05–1.25) >16.7–17.8 776 1.16 (1.07–1.25) 
1.28 to 4.5 >90th >17.9 486 1.49 (1.35–1.64) >17.8 415 1.39 (1.25–1.54) 
9 -4.5 to -1.28 <10th <14.2 310 0.88 (0.79–0.99) <14.5 292 0.76 (0.67–0.85) 
-1.28 to -0.68 10th–<25th 14.2–<15.0 654 0.93 (0.85–1.0) 14.5–<15.2 728 0.98 (0.91–1.07) 
-0.68 to 0.68 25th–75th 15.0–17.3 2617 1.00 (reference) 15.2–17.2 2909 1.00 (reference) 
0.68 to 1.28 >75th–90th >17.3–18.7 669 1.13 (1.04–1.23) >17.2–18.4 773 1.23 (1.14–1.34) 
1.28 to 4.5 >90th >18.7 498 1.48 (1.34–1.63) >18.4 421 1.42 (1.28–1.58) 
10 -4.5 to -1.28 <10th <14.4 306 0.91 (0.81–1.03) <14.7 304 0.77 (0.68–0.86) 
-1.28 to -0.68 10th–<25th 14.4–<15.3 622 0.88 (0.80–0.96) 14.7–<15.5 703 0.90 (0.83–0.98) 
-0.68 to 0.68 25th–75th 15.3–17.8 2619 1.00 (reference) 15.5–17.7 2966 1.00 (reference) 
0.68 to 1.28 >75th–90th >17.8–19.4 683 1.14 (1.05–1.24) >17.7–19.1 694 1.15 (1.05–1.24) 
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11 -4.5 to -1.28 <10th <14.7 297 0.91 (0.81–1.02) <15.0 312 0.80 (0.71–0.90) 
-1.28 to -0.68 10th–<25th 14.7–<15.6 619 0.90 (0.82–0.98) 15.0–<15.8 726 0.91 (0.84–0.99) 
-0.68 to 0.68 25th–75th 15.6–18.4 2564 1.00 (reference) 15.8–18.2 2927 1.00 (reference) 
0.68 to 1.28 >75th–90th >18.4–20.1 719 1.20 (1.11–1.31) >18.2–19.8 690 1.16 (1.07–1.26) 
1.28 to 4.5 >90th >20.1 508 1.55 (1.41–1.71) >19.8 439 1.42 (1.29–1.58) 
12 -4.5 to -1.28 <10th <15.1 284 0.88 (0.78–0.99) <15.3 312 0.83 (0.73–0.93) 
-1.28 to -0.68 10th–<25th 15.1–<16.1 608 0.91 (0.83–1.00) 15.3–<16.1 714 0.91 (0.84–0.99) 
-0.68 to 0.68 25th–75th 16.1–19.1 2524 1.00 (reference) 16.1–18.8 2885 1.00 (reference) 
0.68 to 1.28 >75th–90th >19.1–21.0 755 1.22 (1.12–1.32) >18.8–20.5 696 1.14 (1.05–1.24) 
1.28 to 4.5 >90th >21.0 516 1.54 (1.4–1.70) >20.5 470 1.47 (1.33–1.62) 
BMI, body-mass index (kg/m2); CI, confidence interval; HR, hazard ratio D
ow
nloaded from
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Table S3. Test of the proportional hazards assumption in the association between body-
mass index and venous thromboembolism* 
Categorical model Restricted cubic spline (4 knots) 
Women Men Women Men 
Age 
(y) 
p-value p-value p-value p-value
7 0.25 <0.001 0.12 0.01 
8 0.05 0.04 0.14 0.04 
9 0.43 0.35 0.35 0.15 
10 0.56 0.18 0.51 0.16 
11 0.46 0.10 0.76 0.11 
12 0.15 0.52 0.30 0.12 
13 0.15 0.45 0.25 0.06 
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Table S4. Body-mass index category in childhood and risk of provoked and unprovoked venous thromboembolism in adulthood.














HR (95% CI) N 
No. of 
events 
HR (95% CI) 
Women 7 -4.5 to 1.28 <10th <13.8 12,811 139 0.91 (0.76–1.08) 12,698 252 0.99 (0.87–1.13) 
-1.28 to -0.68 10th–<25th 13.8–<14.5 21,869 266 0.96 (0.83–1.09) 21,722 413 0.91 (0.82–1.02) 
-0.68 to 0.68 25th–75th 14.5–16.3 77,078 954 1.00 (reference) 76,478 1,554 1.00 (reference) 
0.68 to 1.28 >75th–90th >16.3–17.3 18,960 221 1.05 (0.91–1.22) 18,770 411 1.17 (1.05–1.31) 
1.28 to 4.5 >90th >17.3 12,577 161 1.38 (1.17–1.63) 12,443 295 1.46 (1.28–1.65) 
13 -4.5 to -1.28 <10th <15.7 9,980 106 0.90 (0.73–1.10) 9,905 181 0.91 (0.78–1.06) 
-1.28 to -0.68 10th–<25th 15.7–<16.7 18,120 210 0.89 (0.77–1.03) 17,995 335 0.87 (0.77–0.98) 
-0.68 to 0.68 25th–75th 16.7–19.9 71,443 949 1.00 (reference) 70,854 1,538 1.00 (reference) 
0.68 to 1.28 >75th–90th >19.9–21.9 20,321 257 1.02 (0.89–1.17) 20,071 507 1.23 (1.11–1.36) 
1.28 to 4.5 >90th >21.9 12,984 205 1.54 (1.33–1.80) 12,829 360 1.58 (1.41–1.77) 
Men 7 -4.5 to -1.28 <10th <14.0 13,002 106 0.77 (0.63–0.94) 12,849 259 0.85 (0.75–0.97) 
-1.28 to -0.68 10th–<25th 14.0–<14.6 21,193 221 0.93 (0.80–1.08) 20,884 530 1.02 (0.93–1.13) 
-0.68 to 0.68 25th–75th 14.6–16.3 79,789 884 1.00 (reference) 78,759 1,914 1.00 (reference) 
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1.28 to 4.5 >90th >17.2 12,210 124 1.30 (1.08–1.57) 12,041 293 1.35 (1.20–1.53) 
13 -4.5 to -1.28 <10th <15.6 10,230 84 0.77 (0.61–0.96) 10,097 217 0.87 (0.75–1.00) 
-1.28 to -0.68 10th–<25th 15.6–<16.5 19,307 195 0.86 (0.74–1.01) 19,051 451 0.90 (0.81–0.99) 
-0.68 to 0.68 25th–75th 16.5–19.4 73,857 872 1.00 (reference) 72,802 1,927 1.00 (reference) 
0.68 to 1.28 >75th–90th >19.4–21.1 18,874 229 1.14 (0.98–1.32) 18,572 531 1.16 (1.06–1.28) 
1.28 to 4.5 >90th >21.1 11,848 156 1.59 (1.34–1.89) 11,670 334 1.43 (1.27–1.60) 
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Table S5. Body-mass index category and risk of deep venous thrombosis (DVT) or pulmonary embolism (PE) in adulthood, by age and sex. 
Women Men 












HR (95% CI) 
No. of 
events 






HR (95% CI) 
No. of 
events 
HR (95% CI) 
7 -4.5 to -1.28 <10th <13.8 240 0.95 (0.83-1.09) 151 1.00 (0.84-1.19) <14.0 262 0.90 (0.79-1.02)    103 0.71 (0.58-0.87) 
-1.28 to -0.68 10th–<25th 13.8–<14.5 450 0.99 (0.89-1.10) 229 0.82 (0.71-0.95) 14.0–<14.6 502 1.00 (0.91-1.11) 249 0.98 (0.86-1.13) 
-0.68 to 0.68 25th–75th 14.5–16.3 1555 1.00 (reference) 953 1.00 (reference) 14.6–16.3 1857 1.00 (reference) 941 1.00 (reference) 
0.68 to 1.28 >75th–90th >16.3–17.3 403 1.17 (1.04-1.30) 229 1.10 (0.95-1.27) >16.3–17.2 520 1.17 (1.06-1.29) 224 1.01 (0.87-1.16) 
1.28 to 4.50 >90th >17.3 293 1.51 (1.33-1.71) 163 1.45 (1.22-1.71) >17.2 291 1.42 (1.25-1.60) 126 1.28 (1.06-1.54) 
13 -4.5 to -1.28 <10th <15.7 177 0.92 (0.78-1.07) 110 0.96 (0.79-1.17 <15.6 2017 0.87 (0.76-1.01) 94 0.81 (0.66-1.00) 
-1.28 to -0.68 10th–<25th 15.7–<16.7 362 0.95 (0.85-1.07) 183 0.78 (0.66-0.91) 15.6–<16.5 437 0.90 (0.82-1.00) 209 0.86 (0.74-1.00) 
-0.68 to 0.68 25th–75th 16.7–19.9 1532 1.00 (reference) 955 1.00 (reference) 16.5–19.4 1861 1.00 (reference) 938 1.00 (reference) 
0.68 to 1.28 >75th–90th >19.9–21.9 491 1.19 (1.08-1.32) 273 1.08 (0.94-1.24) >19.4–21.1 522 1.19 (1.08-1.32) 238 1.11 (0.97-1.28) 
1.28 to 4.50 >90th >21.9 362 1.65 (1.47-1.85) 203 1.57 (1.35-1.83) >21.1 343 1.56 (1.39-1.75) 147 1.44 (1.21-1.72) 
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Figure S2. Birth-weight adjusted restricted cubic spline models for the association between 
body-mass index at ages 7 and 13 years and venous thromboembolism in adulthood. The 
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Figure S3. Childhood body-mass index (BMI) and risk of venous thromboembolism, by birth 
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